MILLENNIUM MANAGEMENT LLC - SYNTA PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$206,000
+186.1%
790,519
+163.5%
0.00%
Q1 2016$72,000
-56.6%
300,049
-36.4%
0.00%
Q4 2015$166,000
-37.8%
472,130
+208.0%
0.00%
-100.0%
Q3 2015$267,000
-57.6%
153,293
-45.7%
0.00%0.0%
Q2 2015$629,000
-3.7%
282,137
-16.2%
0.00%0.0%
Q1 2015$653,000
-65.6%
336,818
-53.1%
0.00%
-75.0%
Q4 2014$1,901,000
+182.9%
717,510
+221.2%
0.00%
+100.0%
Q3 2014$672,000
+6.3%
223,385
+44.6%
0.00%0.0%
Q2 2014$632,000
+276.2%
154,445
+358.3%
0.00%
+100.0%
Q2 2013$168,00033,7000.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 21,704,847$5,209,0007.19%
CAXTON CORP 67,000$16,0000.02%
McQueen, Ball & Associates Inc. 102,742$25,0000.02%
TWO SIGMA SECURITIES, LLC 36,056$9,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,398,330$336,0000.01%
WEDBUSH SECURITIES INC 45,000$11,0000.00%
Roundview Capital LLC 21,100$5,0000.00%
Renaissance Technologies 2,332,995$560,0000.00%
PANAGORA ASSET MANAGEMENT INC 618,599$148,0000.00%
Virtu KCG Holdings LLC 107,071$26,0000.00%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders